Keurig Dr Pepper stock analysis: a Buy signal on a 68/100 score, but 75.6% sales growth is mostly the JDE Peet’s deal and debt is elevated.
Buy
-
-
BiotechnologyFeaturedUS Stocks
Incyte Grows Revenue 37.7% at a 15.46 P/E – Can It Outrun the 2028 Jakafi Patent Cliff?
Incyte stock analysis: INCY grows revenue 37.7% at a 15.46 P/E with a 98/100 Quality score. Why the model rates it a Buy despite the 2028 Jakafi cliff.
-
FeaturedPharmaceuticalsUS Stocks
United Therapeutics Rallies on Its Tyvaso IPF Filing – a 95/100 Quality Score at 19.4 Times Earnings
United Therapeutics stock analysis: UTHR rallies on its Tyvaso IPF filing with a 95/100 Quality score and a 19.40 P/E. Why the model rates it a Buy.
-
FeaturedSoftwareUS Stocks
PicPay Parent PicS N.V. Sits at Its Two-Year Low Despite 67% Revenue Growth
PicS N.V. stock analysis: PicPay’s parent grew revenue 67% yet trades at a two-year low. Quality, growth and valuation scores explained.
-
FeaturedMedia & EntertainmentUS Stocks
Fox Corporation: Modest Multiples and a Strong Balance Sheet Put It Right at the Buy Line
Fox Corporation stock analysis: a 25.2% operating margin, strong liquidity and 7.7x EV/EBITDA put FOXA right at the model’s Buy line.
-
FeaturedSoftwareUS Stocks
Corpay Earns a Buy Signal on Margins and Cash Flow, With Leverage the Main Caveat
Corpay stock analysis: 80.5% gross margins and a 7.3% free cash flow yield earn a model Buy, but debt-to-equity of 2.75 and a near-high price are risks.
-
FeaturedSoftwareUS Stocks
Salesforce Turns $43.9 Billion of Revenue Into $17.7 Billion of Free Cash Flow
Salesforce, Inc. stock analysis: $17.7B free cash flow and an 8.4% FCF yield at a 23x P/E put the model at Buy, with revenue growth slowing to 10.8%.